UiPath Tumbles 16% as Competition Fears Overshadow Strong Q2
PATH sits 65% above its 52-week low of $9.2.
Summary
UiPath shares fell 16% to $15.29 midday Friday despite beating Q2 estimates and raising guidance. The decline reflects investor concerns about intensifying competition in agentic AI, with Oppenheimer noting the beat came from lower costs and services revenue rather than demand acceleration. BMO called execution steady but not impressive, wanting more evidence of sustained growth. This follows yesterday's earnings release and guidance details, but today's price action and analyst skepticism mark a new negative development. Watch for further analyst downgrades or commentary on competitive positioning.
At the time of this announcement, PATH was trading at $15.22 on NYSE in the Technology sector, with a market capitalization of approximately $7.9B. The 52-week trading range was $9.20 to $19.84. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.